Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT02585713

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Phase 3
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02585713
Other papers using this trial's data
  • Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial Journal of thrombosis and haemostasis : JTH, 2020-02 DOI, PubMed 31630479

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02585713. Randomized; no masking; primary purpose supportive care. Start 2015-11-20 (actual); primary completion 2018-04-02 (actual). Results posted on 2019-12-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Condition
Cerebral Vein Thrombosis
Condition
Gonadal Thrombosis
Condition
Hepatic Thrombosis
Condition
Malignant Neoplasm
Condition
Mesenteric Thrombosis
Condition
Metastatic Malignant Neoplasm
Condition
Portal Vein Thrombosis
Condition
Renal Vein Thrombosis
Condition
Splenic Thrombosis
Condition
Venous Thromboembolism
Intervention (Drug)
Apixaban
Intervention (Drug)
Dalteparin
Intervention (Other)
Questionnaire Administration
Lead sponsor
Academic and Community Cancer Research United (class: other)
Collaborator
National Cancer Institute (NCI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct02585713
Content hash
6a93df9db0150237032ca6291ec02ea06eeafd39fa44a1c34e0f405d0878180d